1-benzyl-5-(trifluoromethyl)-1H-pyrazole-3-carboxylic acid

1-benzyl-5-(trifluoromethyl)-1H-pyrazole-3-carboxylic acid

1-(2,2-Diethoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole

1-(2,2-Diethoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole

tert-butyl 4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazine-1-carboxylate

$300.00
CAS No.: 401566-78-7
Catalog No.: LT0261
Purity: 95%
MF: C19H26N4O2
MW: 342.443
Storage: 2-8 degree Celsius
SMILES: CC1=NN(C(=C1)N1CCN(CC1)C(=O)OC(C)(C)C)C1=CC=CC=C1
Availability:
In stock
SKU
LT0261
  • Size
    Price
    Stock
    Estimated Shipping Time
CAS NO.: 401566-78-7;tert-butyl 4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazine-1-carboxylate. PROPERTIES: This methylphenyl pyrazole piperazine presents as a white crystalline solid with a molecular weight of approximately 321.4 g/mol. The tert-butyl 4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazine-1-carboxylate combines a Boc-protected piperazine with a methylphenyl pyrazole ring. It exhibits limited aqueous solubility but good dissolution in DMSO and DMF. Stability characterization reveals sensitivity to acid-catalyzed Boc-deprotection and base-promoted hydrolysis of the ester group, necessitating storage at 2-8 degree Celsius in sealed glass containers. Handlers should use powder hoods with HEPA filtration and wear cut-resistant gloves during handling. Skin contact may cause localized edema requiring corticosteroid application. Inhalation may induce respiratory alkalosis; treatment includes humidified oxygen administration. Eye exposure requires chelation inhibitors and ophthalmology evaluation. Waste should be hydrolyzed with dilute acid prior to disposal. APPLICATIONS: The tert-butyl 4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazine-1-carboxylate serves as a key intermediate in the synthesis of various pharmaceuticals. Its pyrazole piperazine framework provides opportunities for constructing antipsychotic agents and serotonin receptor modulators. Research teams utilize this compound as a starting material for creating kinase inhibitors and muscarinic receptor antagonists. The methylphenyl pyrazole group enhances metabolic resistance in resulting drug candidates. Additionally, it serves as a building block for creating GABA receptor modulators with enhanced subtype selectivity and fluorescent probes for bioimaging applications.

Reviews

Write Your Own Review
You're reviewing:tert-butyl 4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazine-1-carboxylate
Your Rating